Global Cerumenolytic Agents Market, By Drug (Debrox, Others), Chemical Class (Urea compound, hydrogen peroxide), Application (Cerumen Impaction, Others), Dosage (Gel, Solution), Route of Administration (Oral, Topical), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029.
Market Analysis and Size
In recent years, the cerumenolytic agents market is anticipated to grow rapidly during the forecast period. Cerumen is referred to a natural and protective process for the ear canal. Impaction is identified when a build-up of cerumen causes symptoms such as hearing loss or inhibits a thorough examination of the ear canal or tympanic membrane. Manual removal, irrigation, or the application of cerumenolytic drugs, or a combination of these modalities, may be used. Cerumen impaction is a common reason for seeing a primary care physician. It affects roughly 10% of children, 5% of healthy people, up to 57 percent of nursing home residents, and one-third of patients with mental retardation. Hence, these factors are anticipated to increase the demand for cerumenolytic agents in the healthcare sector.
Data Bridge Market Research analyses that the cerumenolytic agents market was valued at USD 55 million in 2021 and is expected to reach USD 85.70 million by 2029, registering a CAGR of 5.70% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Cerumenolytics are medicines that melt solid cerumen (earwax) and make removal easier. Softening agents include different kinds of oil, glycerin, emulsifying agents, and other lubricating compounds. Cerumenolytics agents are inserted into the ears to reduce earwax and relieve discomfort.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Drug (Debrox, Others), Chemical Class (Urea compound, hydrogen peroxide), Application (Cerumen Impaction, Others), Dosage (Gel, Solution), Route of Administration (Oral, Topical), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Prestige Consumer Healthcare Inc. (US), GlaxoSmithKline plc (UK)
|
|
Market Opportunities
|
|
Cerumenolytic Agents Market Dynamics
Drivers
- Increasing incidences of cerumen impaction
The rising incidences of cerumen impaction are anticipated to propel the growth of the cerumenolytic agents market.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of cerumenolytic agents market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the cerumenolytic agents market. Additionally, high disposable income and changing lifestyle of people will result in the expansion of cerumenolytic agents market. Along with this, rising geriatric population and favourable reimbursement policies will enhance the market's growth rate.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the cerumenolytic agents market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.
Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the cerumenolytic agents market growth during the forecast period.
Restraints/Challenges
On the other hand, the high cost associated with the drug development and distribution will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the cerumenolytic agents market. Additionally, side effects linked with cerumenolytic agents and lack of awareness will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This cerumenolytic agents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cerumenolytic agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Cerumenolytic agents market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Cerumenolytic Agents Market
Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations, resulting from multiple precautionary lockdowns and other limitations imposed by governments all over the world. The cerumenolytic agents market is no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors are likely to have a negative impact on the cerumenolytic agents market's revenue trajectory.
Global Cerumenolytic Agents Market Scope
The cerumenolytic agents market is segmented on the basis of drug, chemical class, application, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug
- Debrox
- Others
On the basis of drug, the cerumenolytic agents market is segmented into debrox and others.
Chemical Class
- Urea Compound
- Hydrogen Peroxide
On the basis of chemical class, the cerumenolytic agents market is segmented into urea compound and hydrogen peroxide.
Application
- Cerumen Impaction
- Others
On the basis of application, the cerumenolytic agents market is segmented into cerumen impaction and others.
Dosage
- Gel
- Solution
On the basis of dosage, the cerumenolytic agents market is segmented into gel, and solution.
Route of Administration
- Oral
- Topical
The route of administration segment for the cerumenolytic agents market is segmented into oral, and topical.
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
On the basis of end-users, the cerumenolytic agents market is segmented into hospitals, specialty clinics, homecare and others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
On the basis of distribution channel, the cerumenolytic agents market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
Cerumenolytic Agents Market Regional Analysis/Insights
The Cerumenolytic agents market is analysed and market size insights and trends are provided by country, drug, chemical class, application, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Cerumenolytic agents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the cerumenolytic agents market because of the growing number of research and development activities in this region. Additionally, growing presence of major key players will further propel the market's growth rate in this region.
Asia-Pacific are expected to grow during the forecast period of 2022 to 2029 due to rising healthcare expenditure and improvements in healthcare infrastructure in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Cerumenolytic Agents Market Share Analysis
The Cerumenolytic agents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cerumenolytic agents market.
Some of the major players operating in the cerumenolytic agents market are:
- Prestige Consumer Healthcare Inc. (US)
- GlaxoSmithKline plc (UK)
SKU-